This suggests that TRAIL released from AM in high amounts upon type I IFN stimulation causes substantial collateral damage to the (uninfected) epithelial barrier, especially when macrophages are present in the airspaces in high numbers, as observed during IV pneumonia [6]. This evidence concerns the gene TNFSF10 and pneumonia.